Comparing treatment outcomes of fractional flow reserve-guided and angiography-guided percutaneous coronary intervention in patients with multi-vessel coronary artery diseases: a systematic review and meta-analysis

被引:0
|
作者
Xiu, Jiancheng [1 ]
Chen, Gangbin [1 ]
Zheng, Hua [1 ]
Wang, Yuegang [1 ]
Chen, Haibin [1 ]
Liu, Xuewei [1 ]
Wu, Juefei [1 ]
Bin, Jianping [1 ]
机构
[1] Southern Med Univ, Nanfang Hosp, Dept Cardiol, 1838 North Guangzhou Ave, Guangzhou 510515, Guangdong, Peoples R China
来源
CLINICAL AND INVESTIGATIVE MEDICINE | 2016年 / 39卷 / 01期
关键词
FOLLOW-UP; MYOCARDIAL-INFARCTION; FUNCTIONAL SEVERITY; UNSTABLE ANGINA; REVASCULARIZATION; STENOSIS; FAME; ISCHEMIA; STRATEGY;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Purpose: Fractional flow reserve (FFR)-guided percutaneous coronary intervention (PCI) is used to assess the need for angioplasty in vessels with intermediate blockages. The treatment outcomes of FFR-guided vs. conventional angiography-guided PCI were evaluated in patients with multi-vessel coronary artery disease (CAD). Methods: Prospective and retrospective studies comparing FFR-guided vs. angiography-guided PCI in patients with multi-vessel CAD were identified from medical databases by two independent reviewers using the terms "percutaneous coronary intervention, fractional flow reserve, angiography, coronary heart disease, major adverse cardiac events (MACE) and myocardial infarction". The primary outcome was the number of stents placed, and the secondary outcomes were procedure time, mortality, myocardial infarction (MI) and MACE rates. Results: Seven studies (three retrospective and four prospective), which included 49,517 patients, were included in this review. A total of 4,755 patients underwent FFR, while 44,697 received angiography-guided PCI. The mean patient age ranged from 58 to 71.7 years. The average number of stents used in FFR patients ranged from 0.3-1.9, and in angiography-guided PCI patients ranged from 0.7-2.7. Analysis indicated there was a greater number of stents placed in the angiography-guided group compared with the FFR group (pooled difference in means: -0.64, 95% confidence interval [CI]: -0.81 to -0.47, P < 0.001). There were no differences in the secondary outcomes between the two groups. Conclusions: Both procedures produce similar clinical outcomes, but the fewer number of stents used with FFR may have clinical as was as cost implications.
引用
收藏
页码:E25 / E36
页数:12
相关论文
共 50 条
  • [31] Long-term clinical outcomes of intravascular imaging-guided percutaneous coronary intervention versus angiography-guided percutaneous coronary intervention in complex coronary lesions: a systematic review and meta-analysis
    Ashraf, Danish Ali
    Ahmed, Usman
    Khan, Zainab Zaib
    Mushtaq, Fiza
    Bano, Shehar
    Khan, Ali Raza
    Azam, Saad
    Haroon, Abdullah
    Malik, Salman Ahmed
    Aslam, Raza
    Kumar, Jai
    Khan, Farva Zaib
    Faheem, Amna
    Kumar, Sarwan
    Hassan, Saad
    FUTURE CARDIOLOGY, 2024, 20 (03) : 137 - 150
  • [32] Intravascular Imaging-Guided Versus Angiography-Guided Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Trials
    Sreenivasan, Jayakumar
    Reddy, Rohin K.
    Jamil, Yasser
    Malik, Aaqib
    Chamie, Daniel
    Howard, James P.
    Nanna, Michael G.
    Mintz, Gary S.
    Maehara, Akiko
    Ali, Ziad A.
    Moses, Jeffrey W.
    Chen, Shao-Liang
    Chieffo, Alaide
    Colombo, Antonio
    Leon, Martin B.
    Lansky, Alexandra J.
    Ahmad, Yousif
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (02):
  • [33] Fractional flow reserve (FFR) guided vs angiography guided coronary artery bypass graft (CABG): a systematic review and meta-analysis
    Bruno, F.
    D'Ascenzo, F.
    Marengo, G.
    Manfredi, R.
    Conrotto, F.
    Gallone, G.
    Omede, P.
    Montefusco, A.
    Pennone, M.
    Salizzoni, S.
    Rinaldi, M.
    Giustetto, C.
    De Ferrari, G.
    EUROPEAN HEART JOURNAL, 2020, 41 : 1474 - 1474
  • [34] Intravascular imaging guided versus coronary angiography guided percutaneous coronary intervention: systematic review and meta-analysis
    Khan, Safi U.
    Agarwal, Siddharth
    Arshad, Hassaan B.
    Akbar, Usman Ali
    Mamas, Mamas A.
    Arora, Shilpkumar
    Baber, Usman
    Goel, Sachin S.
    Kleiman, Neal S.
    Shah, Alpesh R.
    BMJ-BRITISH MEDICAL JOURNAL, 2023, 383
  • [35] Evaluating the impact of fractional flow reserve-guided percutaneous coronary intervention in intermediate coronary artery lesions on the mode of treatment and their outcomes: An Iranian experience
    Khosravi, Alireza
    Pourbehi, Mohammad Reza
    Pourmoghaddas, Masoud
    Ostovar, Afshin
    Akhbari, Mohammad Reza
    Ziaee-Bideh, Fereshteh
    Golshahi, Jafar
    Shirani, Shahin
    ARYA ATHEROSCLEROSIS, 2015, 11 (02) : 153 - 159
  • [36] Cost utility of fractional flow reserve-guided percutaneous coronary intervention in multivessel coronary artery disease in Brazil
    Stella, Steffan Frosi
    Polanczyk, Carisi Anne
    Arvandi, Marjan
    Siebert, Uwe
    INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE, 2019, 31 (09) : 676 - 681
  • [37] Fractional Flow Reserve-guided Percutaneous Coronary Intervention: Standing the Test of Time
    Zimmermann, Frederik M.
    van Nunen, Lokien X.
    CARDIOVASCULAR INNOVATIONS AND APPLICATIONS, 2016, 1 (03) : 225 - 232
  • [38] Clinical outcomes of fractional flow reserve-guided percutaneous coronary intervention by coronary flow capacity status in stable lesions
    Hamaya, Rikuta
    Lee, Joo Myung
    Hoshino, Masahiro
    Yonetsu, Taishi
    Koo, Bon-Kwon
    Escaned, Javier
    Kakuta, Tsunekazu
    EUROINTERVENTION, 2021, 17 (04) : E301 - +
  • [39] The effects of fractional flow reserve guided percutaneous coronary intervention: a systematic review and meta-analysis from comparative studies
    Li, Jiehui
    Hua, Kun
    Yang, Xiubin
    CARDIOLOGY, 2013, 126 : 149 - 149
  • [40] Fractional flow reserve-guided percutaneous coronary intervention: Does coronary pressure never lie?
    Van De Hoef T.P.
    Van Lavieren M.A.
    Henriques J.P.S.
    Piek J.J.
    Claessen B.E.P.M.
    Current Treatment Options in Cardiovascular Medicine, 2014, 16 (4)